Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report)’s share price was up 1.3% during trading on Thursday . The company traded as high as $53.89 and last traded at $53.68. Approximately 11,915 shares changed hands during trading, a decline of 62% from the average daily volume of 31,276 shares. The stock had previously closed at $53.01.
Analysts Set New Price Targets
Separately, Royal Bank Of Canada upgraded Sandoz Group from a “hold” rating to a “moderate buy” rating in a report on Friday, May 2nd.
View Our Latest Stock Analysis on SDZNY
Sandoz Group Stock Up 1.3%
About Sandoz Group
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
See Also
- Five stocks we like better than Sandoz Group
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- How to Most Effectively Use the MarketBeat Earnings Screener
- Is IBM’s AI Transformation Powering a Sustained Rally?
- What is the Euro STOXX 50 Index?
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.